.Kazem Rahimi joins me virtually from #ESCCongress to discuss the BPLTTC trial: Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure.
Full interview here: tv.clinicaltrialresults.org/play.php?submi…
#CardioTwitter , what #ESCCongress 🆒 news U can't wait 4 #August 2 end 4 2 🤓?
💌 #ATPCI
💌 #BPLTTC
💌 #BRACECORONA
💌 #EASTAFNET4
💌 #EMPERORReduced
💌 #EXPLORERHCM
💌 #HOMEPE
💌 #IMPACTAfib
💌 #PARALLAX
💌 #POPULARTAVI
💌 #REALITY
Hany Ragy Ritu Thamman MD Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 Julia Grapsa
#ACCWIC
#BPLTTC trial: Blood pressure-lowering treatment prevents #heartattacks and #strokes even in people with normal #bloodpressure bit.ly/2ErOADn
#ESCCongress
Vinay Prasad MD MPH Mark Friedberg This year an individual level data RCT meta-analysis from the BPLTTC suggested once more that lowering BP is good for patients regardless of baseline SBP. SPRINT data appears to be consistent with main findings. Lower is better. thelancet.com/action/showPdf…
#ESCCongress | BPLTTC: blood pressure medication can prevent heart attacks and strokes, regardless of blood pressure levels.
Sociedad Venezolana de Cardiología
#ESC20SVC
Congreso Europeo de Cardiología
#ESCcongress
Clinical Trials- Hot Lines = mañana 31/08/2020:
LoDoCo2
HOME-PE
BPLTTC
José Miguel Torres Viera Ivan Mendoza Igor Morr Carlos I Ponte N Lempira Guevara Matheus Emilia Martinez Heydi Lara Josefa Feijoo Sociedad Venezolana de Cardiología
#BPLTTC trial: used data from 348,854 individuals in 48 randomised clinical trials to assess the effect of #bloodpressure treatment on #cardiovascular events bit.ly/2ErOADn
#ESCCongress
Important patient-level metaanalysis from BPLTTC just published. Pharmacological Rx can prevent outcomes even at normal or high normal baseline BP. Dr Anastasia Mihailidou FAHA FCSANZ FESC Tanja Dudenbostel, MD, FASH, FAHA Erika Campana “OTO PA-TA-MAR” ❤️🖤 Erin D. Michos, M.D. Daichi Shimbo MD Prof Kausik Ray FMedSci Pablo Corral MD Nicolas Renna, MD PhD ISHF FESC Henry Han
#ESCCongress #BPLTTC #CVprevention
♥️No evidence that the effect differed by level of SBP interestingly, even if SBP <120 and this was true for primary & secondary prevention
♥️Ultimately control of BP is just as important in those without CVD 🆚 those with CVD
👏Amazing Study
BPLTTC: Can BP-Lowering Medication Help Prevent Heart Attack, Stroke Regardless of BP Levels? | ESC Congress 2020 Sociedad Venezolana de Cardiología svcardiologia.org/es/esc2020/528…
Daniel Piskorz
Daniel Piskorz
·
12s
Invito a leer el análisis y discusión del meta-análisis BPLTTC presentado en el Congreso Europeo Virtual de Cardiología disponible en siacardio.com/wp-content/upl……
News: Blood pressure reduction prevents a similar absolute number of events regardless of the presence of #Type2Diabetes , shows a meta-analysis from the #BPLTTC Milad Nazarzadeh Richard McManus george davey smith Amanda I Adler Kazem Rahimi The Lancet Diabetes & Endocrinology bit.ly/3S55713
#BPLTTC : Blood Pressure-Lowering Treatment Prevents MI and Strokes Even in People with Normal BP, +/- Prior CVD.
lowering BP matters with or without CAD!! European Society of Cardiology #ESCCongress
📌Late Breaking Trials
#ESCCongress 2020
#HeartFailure #IC #HF
🏆EMPEROR-Reduced 1️⃣
🏆EXPLORER-HCM 2️⃣
🏆PARALLAX 6️⃣
And more
•More:
•EAST-AFNET 4
•ATPCI
•POPULAR TAVI
•LoDoCo2
•HOME-PE
•BPLTTC
•BEACE-CORONA
•IMPACT-Afib
•REALITY
#cardioEd #cardiotwitter
European Society of Cardiology
..and BPLTTC showed relative treatment effect on BP lowering to be constant, regardless of whether CVD present at baseline or not, AND regardless of baseline BP to <120mmHg !! Included 30-50% women👩👩🏽👩🏼👩🏻 #ESCCongress Dr Anastasia Mihailidou FAHA FCSANZ FESC Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Ritu Thamman MD Thais Coutinho